NCT00804154 2026-03-18
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07447856 2026-03-04
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06644573 2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1 Not yet recruiting
NCT03226574 2020-10-20
Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Phase 1 Completed
NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT01846429 2015-06-04
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT00804076 2014-02-19
Gene Transfer for Cancer Pain
Diamyd Inc
Phase 1 Completed
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed